Researcher and pediatric clinician - thrilled to integrate clinical experience into clinical research and vice versa. Special interest in infectious and tropical diseases. Passionate to explore other research topics and integrate knowledge from other domains: environmental sciences, microbiology, PK/PD research, biostatistics, immunology, etc. Together we are stronger - tous ensemble!

Pediatric resident, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University / Dr. Sardjito Hospital

Dr. Tan is Professor of Pediatrics at the Feinberg School of Medicine, Northwestern University, and a Pediatric Infectious Diseases attending; Medical Director of the International Patient and Destination Services Program (IPS); co-Director of the Pediatric Travel Medicine Clinic; and Director of the International Adoptee Clinic at Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois. She is board certified in Pediatrics and Pediatric Infectious Diseases. Dr. Tan recently served as a member of the Board of Directors of the Infectious Diseases Society of America (IDSA – 2017-2020). She also is a member of the IDSA Education Committee and the chairperson of the IDSA Committee on Diversity, Inclusion, Access & Equity. She currently serves as chairperson of the: American Academy of Pediatrics Global Immunization Advocacy Project Advisory Committee and is a Technical Advisor for the AAP/CDC Global Immunization Advocacy Project; AAP Expert Pertussis Cocooning Advisory Committee, and is a liaison to the CDC ACIP Pertussis Working Group and to the Illinois Chapter of the AAP OB/GYN Immunizations and Pregnancy Outreach Committee. She is a member of the American Board of Pediatrics (ABP) Global Health Task Force Dissemination and Advocacy Work Group. Dr. Tan is a member of: the Vaccine and Related Biologic Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) and the Board of Scientific Counselors, Office of Infectious Diseases, Centers for Disease Control and Prevention (CDC) where she serves as co-Chair of the AFM Task Force and the Vaccine Confidence Task Force. She is the Editor-in-Chief of Contemporary Pediatrics and the American Academy of Pediatrics Redbook Atlas of Pediatric Infectious Diseases and the Redbook: A Quick Diagnostic Deck. She serves on the editorial boards of: the Journal of the Pediatric Infectious Diseases Society (Official Journal of the Pediatric Infectious Diseases Society - PIDS), Internal Medicine Reviews, and Vaccines. She is the Co-Chairperson and US Representative to the International Steering Committee of the Global Pertussis Initiative (GPI); a member and consultant to the Steering Committee of the Latin America Without Pertussis Initiative (PAHEF, SLIPE); a member of the Expert Pertussis Core Team for Latin America & the Caribbean: Pertussis Action Plan 2020; a member of the Board of Directors of the World Association of Infectious Diseases and Immunological Disorders (WAidid); and a member of the US National Pertussis Task Force (AAP and Every Child by Two). She also is a member of the vaccine advisory boards of Merck, Sanofi Pasteur, GSK and Pfizer/Wyeth. Her interests include: pertussis disease and vaccines, pneumococcal disease and vaccines, CA-MRSA infections, antibiotic resistance, vaccines and vaccine preventable diseases, general infectious diseases, vaccination of cancer patients with routinely recommended adult preventative vaccines, and vaccine education for healthcare providers and patients.

I have completed MD in Preventive Social Medicine in 2001. I worked as Epidemiologist-cum-Lecturer in a medical school during 200-04. I am working as an Epidemiologist in the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) Pune since 2004. The work mostly involves response to outbreaks for clinical and field epidemiological investigations along with surveys and surveillance research studies on emerging, neglected tropical, vaccine-preventable, and vector-borne virus diseases. Vaccine evaluations in post-licensure conditions are also undertaken along with disease burden estimation, modelling transmission and vaccination impact assessments.

Professor Usa Thisyakorn is an Executive Director of Tropical Medicine Cluster, Chulalongkorn University; an Advisor of Faculty of Tropical Medicine, Mahidol University, Department of Health, Bangkok Metropolitan Administration and Faculty of Medicine, Thammasat University. Her additional positions include Dengue Advisory Group of International Society for Neglected Tropical Diseases, Steering Committee Member of Asia Dengue Voice and Action, Council Member of World Society for Virology, Board Member of World Society for Pediatric Infectious Diseases, Past President of International Society of Tropical Pediatrics, Asian Society for Pediatric Infectious Diseases, Pediatric Society of Thailand as well as Pediatric Infectious Disease Society of Thailand. In 1989, she received a Rockefeller grant for dengue research at the Centers for Diseases Control and Prevention in Atlanta and Scientific Awards in 1994 from the Elizabeth Glaser Pediatric AIDS Foundation for Pediatric HIV training at the National Institutes of Health in Bethesda. In 2000, under Professor Thisyakorn’s guidance as Chair of the Medical Committee on the Save a child’s life from AIDS Project, the project was selected as one of the UNAIDS best practices in the year 2000. This project has contributed significantly to the recognition of Thailand by the World Health Organization as the first country in Asia to successfully eliminate mother-to-child transmission of HIV in 2015. For her contributions, she has received several awards including Woman of the Year from the Foundation for Thai Society, The Outstanding Asian Pediatrician from the Asia Pacific Pediatric Association and The Outstanding Woman in the International Stage/Network from Ministry of Social Development and Human Security on the occasion of the International Women’s day 2019. Professor Thisyakorn has served as an editorial board of several medical journals and has contributed over 150 indexed publications to date.

Juan Pablo Torres, MD, PhD, is the director of innovation at the University of Chile in Santiago, Chile. From 2006 to 2019, he worked as a consultant in the Pulmonary Department at the University of Navarra in Pamplona, Spain, where he also obtained a doctorate degree in medicine. He is an accomplished clinical researcher, who was a principal investigator of the International Lung Cancer Action Program (I-ELCAP) and the national delegate for Spain at the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines Committee. His main clinical and research interests are COPD and lung cancer screening. Dr Torres graduated as a medical doctor from the University of the Republic in Montevideo, Uruguay, in 1991. He completed an internal medicine residency at the University of Miami and a pulmonary and critical care fellowship at Tufts University in Boston, MA.

Dr. Adriana Tremoulet is a Professor of Clinical Pediatrics in the Division of Host-Microbe Systems and Therapeutics in the Department of Pediatrics at UC San Diego, specializing in pediatric infectious diseases, Kawasaki disease (KD), Multisystem Inflammatory Syndrome in Children (MIS-C), and pediatric clinical pharmacology. She has served as the Associate Director of the KD Research Center at UC San Diego since 2007, where her research focuses on repurposing therapeutics in Phase I through III clinical trials, including infliximab, atorvastatin and anakinra for KD patients. She has a passion for pediatric pharmacology and served as the co-principal investigator of the NICHD-funded UC San Diego Research Program in Developmental Pharmacology. She is currently a co-PI of the NICHD-funded Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub, co-Director of the NICHD-funded UC San Diego Pediatric Clinical Pharmacology T32 Training Program and co-director of the Altman Clinical Trials Research Institute KL2 program. As a native Spanish speaker, she has established the KD Latin American Network, which engages more than 300 investigators from 20 Latin American countries in collecting prospective data from KD and MIS-C patients. She is the Chair of the American Heart Association’s Rheumatic Fever, Endocarditis and Kawasaki Disease Committee. She is passionate about training the next generation of diverse physician-scientists.